FOLH1 and neoplasm: Next, we conducted the PET/CT imaging study of [68Ga]Ga-DOTA-AmBz-MVK(HTK01166)-OH in mice bearing PSMA-expressing LNCaP tumor xenografts to evaluate its pharmacokinetics and PSMA-targeting capability.